AU627188B2 - Pharmaceutical products - Google Patents

Pharmaceutical products Download PDF

Info

Publication number
AU627188B2
AU627188B2 AU36272/89A AU3627289A AU627188B2 AU 627188 B2 AU627188 B2 AU 627188B2 AU 36272/89 A AU36272/89 A AU 36272/89A AU 3627289 A AU3627289 A AU 3627289A AU 627188 B2 AU627188 B2 AU 627188B2
Authority
AU
Australia
Prior art keywords
compound
formula
antiviral
compounds
azido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36272/89A
Other languages
English (en)
Other versions
AU3627289A (en
Inventor
William M. Shannon
Robert Vince
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Southern Research Institute
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of AU3627289A publication Critical patent/AU3627289A/en
Application granted granted Critical
Publication of AU627188B2 publication Critical patent/AU627188B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU36272/89A 1988-06-10 1989-06-09 Pharmaceutical products Ceased AU627188B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20516388A 1988-06-10 1988-06-10
US205163 1988-06-10

Publications (2)

Publication Number Publication Date
AU3627289A AU3627289A (en) 1989-12-14
AU627188B2 true AU627188B2 (en) 1992-08-20

Family

ID=22761073

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36272/89A Ceased AU627188B2 (en) 1988-06-10 1989-06-09 Pharmaceutical products

Country Status (9)

Country Link
EP (1) EP0346132B1 (enExample)
JP (1) JPH0291022A (enExample)
AT (1) ATE73335T1 (enExample)
AU (1) AU627188B2 (enExample)
DE (1) DE68900961D1 (enExample)
DK (1) DK284189A (enExample)
GR (1) GR3004628T3 (enExample)
NZ (1) NZ229453A (enExample)
ZA (1) ZA894392B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62275B1 (en) * 1988-01-20 1995-01-25 Univ Minnesota Dideoxydidehydrocarbocyclic nucleosides
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
GB2243609B (en) * 1988-01-20 1992-03-11 Univ Minnesota Dideoxydidehydrocarbocyclic pyrimidines
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
EP0879056B1 (en) * 1996-01-23 2002-05-02 ICN Pharmaceuticals, Inc. Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes
JP2002515892A (ja) * 1997-01-17 2002-05-28 アイ・シー・エヌ・フアーマシユーテイカルズ・インコーポレイテツド サイトカインが関係する疾患治療法
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
IL136549A (en) * 1997-12-22 2005-05-17 Schering Corp Orally administrable solid ribavirin dosage forms and process for making them
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
EA200601591A1 (ru) 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Применение рибонуклеозидных соединений для лечения флавивирусных и пестивирусных инфекций
BR0311141A (pt) * 2002-06-27 2005-06-07 Medivir Ab Interação sinergìstica de abacavir e alovudine
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
ES2624353T3 (es) 2002-11-15 2017-07-13 Idenix Pharmaceuticals Llc 2'-Metil nucleósidos en combinación con interferón y mutación de Flaviviridae
CN101233135B (zh) * 2005-05-05 2012-10-03 阿迪亚生命科学公司 用作非核苷反转录酶抑制剂治疗人免疫缺陷病毒的二芳基-嘌呤、二芳基-氮杂嘌呤和二芳基-脱氮嘌呤化合物
US7968521B2 (en) 2005-06-24 2011-06-28 Yamasa Corporation Stable cystal of protected pseudouridine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
AU4607489A (en) * 1988-12-14 1990-06-21 Novartis Ag 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4362729A (en) * 1980-06-23 1982-12-07 The Regents Of The University Of Minnesota Alkoxyalkanoate esters of cyclaradine
US4636383A (en) * 1984-08-29 1987-01-13 Schering Corporation Interferon-cyclaradine combination

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
AU4607489A (en) * 1988-12-14 1990-06-21 Novartis Ag 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition

Also Published As

Publication number Publication date
JPH0291022A (ja) 1990-03-30
ZA894392B (en) 1990-08-29
EP0346132A1 (en) 1989-12-13
DK284189A (da) 1989-12-11
EP0346132B1 (en) 1992-03-11
AU3627289A (en) 1989-12-14
NZ229453A (en) 1991-08-27
ATE73335T1 (de) 1992-03-15
DE68900961D1 (de) 1992-04-16
GR3004628T3 (enExample) 1993-04-28
DK284189D0 (da) 1989-06-09

Similar Documents

Publication Publication Date Title
AU627188B2 (en) Pharmaceutical products
US4916224A (en) Dideoxycarbocyclic nucleosides
US6072053A (en) Dideoxycarbocyclic nucleosides
US5122517A (en) Antiviral combination comprising nucleoside analogs
AU626278B2 (en) Dideoxydidehydrocarbocyclic nucleosides
FI87783C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2',3'-dideoxinukleosider
US4950758A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
SA95160202B1 (ar) مضادات للفيروسات من مشتقات بنزاميداوزل نيكلوسيدية وطريقة تحضيرها
EP0675724B1 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
US4931559A (en) Optically-active isomers of dideoxycarbocyclic nucleosides
EP0285432B1 (en) Therapeutic nucleosides
AU760875B2 (en) Antiviral nucleoside analogues
US5567703A (en) Method for treating HIV infections with dideoxycarbocyclic nucleosides
US5175292A (en) Intermediates for the preparation of dideoxycarbocyclic nucleosides
GB2243609A (en) Carbocyclic nucleosides
HK1002426B (en) Use of dideoxy nucleoside analogues in the treatment of viral infections